Stock Report

All about this stock under one free report Last Updated: 06-Sep-2026

Stock Rating

Is this stock worth it? Our ratings reveal the truth.

Wealth Insight New Issue

This month’s issue could change how you invest, read now.

Recently Viewed

Clear All

Biopol Chemicals Key Ratios

Stock Card factsheet watchlist-stock-modal share-fund-plan-icon

NSE: BIOPOL

₹45.75

up-down-arrow ₹2.15 (4.93%)

As on 04-Sep-2026 15:50IST

Market cap

info icon

₹49 Cr

Revenue (TTM)

info icon

₹49 Cr

P/E Ratio

info icon

5.5

P/B Ratio

info icon

1

Div. Yield

info icon

0 %

Key Ratios and Highlights

Growth Score (%) Quarterly Annual (TTM)
Particulars QoQ YoY 1-Year 3-Years 5-Years
Revenue -- -- 181.82 -- --
EBIT -- -- 251.99 -- --
Net Profit -- -- 238.08 -- --
EPS -- -- 238.08 -- --
Book Value -- -- 47.06 -- --
Key Ratios (%) Average Annual (TTM)
Particulars3-Years5-YearsMar-25Mar-24Mar-23
EBIT-Margin info ----13.1610.53--
Net Margin info ----8.81----
Return on equity info ----38.1013.92--
Return on Capital info ----38.1614.37--
Return on Assets info ----17.697.31--
Debt to Equity (x) info ----0.570.39--

Profitability

View Detailed Peer Comparison

ROCE

38.16

Higher than Peers by 26.10

Earning before interest and taxes / (Average net worth + Average total Debt) * 100

Company Name
Mar-25
Mar-24
Mar-23
Mar-22
Mar-21
Biopol Chemicals
38.16
14.37
--
--
--
Peer Median
12.06
13.53
--
21.96
20.41
ROE

38.10

Higher than Peers by 29.19

Profit after tax / Average Net worth * 100

Company Name
Mar-25
Mar-24
Mar-23
Mar-22
Mar-21
Biopol Chemicals
38.10
13.92
--
--
--
Peer Median
8.91
10.80
--
16.28
17.76
ROA

17.69

Higher than Peers by 12.05

Profit after tax / Average Total assets * 100

Company Name
Mar-25
Mar-24
Mar-23
Mar-22
Mar-21
Biopol Chemicals
17.69
7.31
--
--
--
Peer Median
5.64
6.79
--
12.29
10.41
EBIT Margin

13.16

Higher than Peers by 4.72

Operating profit (EBIT) / Net Sales * 100

Company Name
Mar-25
Mar-24
Mar-23
Mar-22
Mar-21
Biopol Chemicals
13.16
10.53
--
--
--
Peer Median
8.43
8.97
--
11.95
13.00
Net Margin

8.81

Higher than Peers by 2.85

Net profit / Total Income (Net sales plus other income) * 100

Company Name
Mar-25
Mar-24
Mar-23
Mar-22
Mar-21
Biopol Chemicals
8.81
7.35
--
--
--
Peer Median
5.96
6.62
--
9.57
9.41
Cash Profit Margin

8.96

--

(Net profit + Depreciation) / Gross Sales * 100

Company Name
Mar-25
Mar-24
Mar-23
Mar-22
Mar-21
Biopol Chemicals
8.96
7.58
--
--
--
Peer Median
--
--
--
--
--

Growth

View Detailed Peer Comparison

Revenue Growth

181.82

Higher than Peers by 172.39

Year on year growth in net sales

Company Name
Mar-25
Mar-24
Mar-23
Mar-22
Mar-21
Biopol Chemicals
181.82
--
--
--
--
Peer Median
9.42
9.36
--
29.50
44.59
EBIT Growth

251.99

Higher than Peers by 250.20

Year on year growth in operating profit (EBIT)

Company Name
Mar-25
Mar-24
Mar-23
Mar-22
Mar-21
Biopol Chemicals
251.99
--
--
--
--
Peer Median
1.79
-1.67
--
8.94
67.96
Net Profit Growth

238.08

Higher than Peers by 239.17

Year on year growth in profit after tax

Company Name
Mar-25
Mar-24
Mar-23
Mar-22
Mar-21
Biopol Chemicals
238.08
--
--
--
--
Peer Median
-1.10
4.91
--
13.50
100.21
EPS Growth

238.08

Higher than Peers by 237.93

Year on year growth in earnings per share

Company Name
Mar-25
Mar-24
Mar-23
Mar-22
Mar-21
Biopol Chemicals
238.08
--
--
--
--
Peer Median
0.15
4.91
--
--
100.20
Book Value Growth

47.06

--

Year on year growth in book value per share

Company Name
Mar-25
Mar-24
Mar-23
Mar-22
Mar-21
Biopol Chemicals
47.06
--
--
--
--
Peer Median
--
--
--
--
--

Solvency

View Detailed Peer Comparison

Debt to Equity

0.57

Higher than Peers by 0.41

Total debt / Net worth

Company Name
Mar-25
Mar-24
Mar-23
Mar-22
Mar-21
Biopol Chemicals
0.57
0.39
--
--
--
Peer Median
0.16
0.08
--
0.13
0.14
Short term debt to equity ratio

0.50

--

(Short term borrowings / Net worth)

Company Name
Mar-25
Mar-24
Mar-23
Mar-22
Mar-21
Biopol Chemicals
0.50
0.39
--
--
--
Peer Median
--
--
--
--
--
Current Ratio

1.81

Lower than Peers by 0.42

Current Assets / Current Liabilities and Provisions

Company Name
Mar-25
Mar-24
Mar-23
Mar-22
Mar-21
Biopol Chemicals
1.81
2.08
--
--
--
Peer Median
2.23
2.18
--
1.93
1.82
Quick Ratio

1.12

Lower than Peers by 0.83

(Current Assets - Inventory) / Current Liabilities and Provisions

Company Name
Mar-25
Mar-24
Mar-23
Mar-22
Mar-21
Biopol Chemicals
1.12
1.34
--
--
--
Peer Median
1.96
1.71
--
1.31
1.28
Interest Coverage

9.52

Higher than Peers by 0.67

Earning before interest and taxes (EBIT) / Interest Expenses

Company Name
Mar-25
Mar-24
Mar-23
Mar-22
Mar-21
Biopol Chemicals
9.52
14.80
--
--
--
Peer Median
8.85
10.17
--
14.41
11.56

Operating Efficiency

View Detailed Peer Comparison

Debtors to sales

33.90

Higher than Peers by 15.58

Debtors outstanding / Net Sales * 100

Company Name
Mar-25
Mar-24
Mar-23
Mar-22
Mar-21
Biopol Chemicals
33.90
58.12
--
--
--
Peer Median
18.32
17.58
--
17.99
15.79
Asset Turnover

2.01

Higher than Peers by 1.16

Sales / Average Total Assets

Company Name
Mar-25
Mar-24
Mar-23
Mar-22
Mar-21
Biopol Chemicals
2.01
0.99
--
--
--
Peer Median
0.84
0.85
--
1.11
1.35
Receivable days

99.51

--

Average Debtors / Sales * 365

Company Name
Mar-25
Mar-24
Mar-23
Mar-22
Mar-21
Biopol Chemicals
99.51
212.12
--
--
--
Peer Median
--
--
--
--
--
Inventory Days

66.67

--

Average Inventory / Sales * 365

Company Name
Mar-25
Mar-24
Mar-23
Mar-22
Mar-21
Biopol Chemicals
66.67
128.41
--
--
--
Peer Median
--
--
--
--
--
Payable days

56.07

--

Average Creditors / Cost of goods sold * 365

Company Name
Mar-25
Mar-24
Mar-23
Mar-22
Mar-21
Biopol Chemicals
56.07
95.77
--
--
--
Peer Median
--
--
--
--
--
Cash Conversion Cycle

110.11

--

Receivable Days + Inventory Days - Payable Days

Company Name
Mar-25
Mar-24
Mar-23
Mar-22
Mar-21
Biopol Chemicals
110.11
244.77
--
--
--
Peer Median
--
--
--
--
--

Valuation

View Detailed Peer Comparison

Price / Earnings

--

--

Current share price divided by earning per share in the last twelve months

Company Name
Mar-25
Mar-24
Mar-23
Mar-22
Mar-21
Biopol Chemicals
--
--
--
--
--
Peer Median
35.43
34.02
--
27.79
30.46
Price / Book Value

--

--

Current share price divided by book value per share in the latest financial year

Company Name
Mar-25
Mar-24
Mar-23
Mar-22
Mar-21
Biopol Chemicals
--
--
--
--
--
Peer Median
2.26
2.74
--
3.55
4.51
EV/EBITDA

2.20

Lower than Peers by 21.47

Enterprise Value (Current Market Capitalisation + Total Debt - Cash & Equivalents) / Earnings before interest, taxes, depreciation and taxes (EBITDA)

Company Name
Mar-25
Mar-24
Mar-23
Mar-22
Mar-21
Biopol Chemicals
2.20
6.08
--
--
--
Peer Median
23.67
19.92
--
19.44
27.85
Market Cap

--

--

Current Share price multiplied by latest total number of shares outstanding

Company Name
Mar-25
Mar-24
Mar-23
Mar-22
Mar-21
Biopol Chemicals
--
--
--
--
--
Peer Median
920
1,568
--
1,526
1,865
loading...
loading...
loading...